Evidence map›Paper›PMID 37943614›Full record

ArticleJCI insight2023

HNF1α maintains pancreatic α and β cell functions in primary human islets.

Mollie F Qian, Romina J Bevacqua, Vy Mn Coykendall, Xiong Liu, Weichen Zhao, Charles A Chang, Xueying Gu, Xiao-Qing Dai, Patrick E MacDonald, Seung K Kim

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Mollie F QianDepartment of Developmental Biology, Stanford University School of Medicine, Stanford, California, USA.
Romina J BevacquaDepartment of Developmental Biology, Stanford University School of Medicine, Stanford, California, USA.
Vy Mn CoykendallDepartment of Developmental Biology, Stanford University School of Medicine, Stanford, California, USA.
Xiong LiuDepartment of Pharmacology and.
Weichen ZhaoDepartment of Developmental Biology, Stanford University School of Medicine, Stanford, California, USA.
Charles A ChangDepartment of Developmental Biology, Stanford University School of Medicine, Stanford, California, USA.
Xueying GuDepartment of Developmental Biology, Stanford University School of Medicine, Stanford, California, USA.
Xiao-Qing DaiDepartment of Pharmacology and.
Patrick E MacDonaldDepartment of Pharmacology and.
Seung K KimDepartment of Developmental Biology, Stanford University School of Medicine, Stanford, California, USA.
Stanford University · USUniversity of Alberta · CAStanford Health Care · US

Funding

Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
The Human Islet Distribution Coordinating Center (UC4)UC4DK098085 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI EVANS-MOLINA, CARMELLA, NILAND, JOYCE CAROL · 2012 to 2017
$25.6M
Stanford Islet Research CoreP30DK116074 · NIDDK · STANFORD UNIVERSITY · PI Seung K Kim · 2017 to 2026
$19.5M
GENETICS TRAINING PROGRAM FOR PHD CANDIDATEST32GM007790 · NIGMS · STANFORD UNIVERSITY · PI BRUNET, ANNE, KINGSLEY, DAVID M · 1985 to 2020
$12.8M
Therapeutic targeting of human islets with recombinant regulatory T cellsU01DK123743 · NIDDK · STANFORD UNIVERSITY · PI KIM, SEUNG K, MEYER, EVERETT · 2019 to 2022
$2.9M
Genetic and physiologic regulation of pig islet development and functionR01DK128932 · NIDDK · STANFORD UNIVERSITY · PI BERGER, TRISH, KIM, SEUNG K · 2021 to 2024
$2.6M
In vivo systems to discover mechanisms regulating human islet alpha cell functionR01DK126482 · NIDDK · STANFORD UNIVERSITY · PI KIM, SEUNG K, MACDONALD, PATRICK · 2020 to 2023
$2.2M
Regulation of gastrointestinal hormone signaling and metabolism by Neuromedin UR01DK107507 · NIDDK · STANFORD UNIVERSITY · PI KIM, SEUNG K · 2017 to 2021
$2.0M
Discovering genetic and hormonal mechanisms underlying diabetes risk from flies to humansR01DK108817 · NIDDK · STANFORD UNIVERSITY · PI KIM, SEUNG K · 2018 to 2022
$2.0M
Ultra high throughput sequencer for sustaining and enhancing multi-scale genomic studiesS10OD025212 · OD · STANFORD UNIVERSITY · PI SNYDER, MICHAEL P. · 2018 to 2018
$600k
Computer ClusterS10OD021763 · OD · STANFORD UNIVERSITY · PI JI, HANLEE P · 2016 to 2016
$481k
Identification of Novel Regulatory Mechanisms Driving Human beta-Cell Maturation and Function.R03DK138492 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BEVACQUA, ROMINA · 2024 to 2025
$338k
NIDDK NIH HHS P30 DK020593NIDDK NIH HHS P30 DK116074NIDDK NIH HHS R01 DK107507NIDDK NIH HHS R01 DK108817NIDDK NIH HHS R01 DK126482NIDDK NIH HHS R01 DK128932NIDDK NIH HHS R03 DK138492NIDDK NIH HHS U01 DK123743NIDDK NIH HHS UC4 DK098085NIGMS NIH HHS T32 GM007790NIH HHS S10 OD021763NIH HHS S10 OD025212
6 · The paper itself

Abstract

HNF1A haploinsufficiency underlies the most common form of human monogenic diabetes (HNF1A-maturity onset diabetes of the young [HNF1A-MODY]), and hypomorphic HNF1A variants confer type 2 diabetes risk. But a lack of experimental systems for interrogating mature human islets has limited our understanding of how the transcription factor HNF1α regulates adult islet function. Here, we combined conditional genetic targeting in human islet cells, RNA-Seq, chromatin mapping with cleavage under targets and release using nuclease (CUT&RUN), and transplantation-based assays to determine HNF1α-regulated mechanisms in adult human pancreatic α and β cells. Short hairpin RNA-mediated (shRNA-mediated) suppression of HNF1A in primary human pseudoislets led to blunted insulin output and dysregulated glucagon secretion after transplantation in mice, recapitulating phenotypes observed in patients with diabetes. These deficits corresponded with altered expression of genes encoding factors critical for hormone secretion, including calcium channel subunits, ATPase transporters, and extracellular matrix constituents. Additionally, HNF1A loss led to upregulation of transcriptional repressors, providing evidence for a mechanism of transcriptional derepression through HNF1α. CUT&RUN mapping of HNF1α DNA binding sites in primary human islets imputed a subset of HNF1α-regulated genes as direct targets. These data elucidate mechanistic links between HNF1A loss and diabetic phenotypes in mature human α and β cells.

Indexed as

Diabetes Mellitus, Type 2Insulin-Secreting CellsAnimalsGene Expression RegulationHepatocyte Nuclear Factor 1-alphaHumansInsulinMicePancreasHepatocyte Nuclear Factor 1-alphaHNF1A protein, humanInsulinBeta cellsDiabetesEndocrinologyGeneticsMonogenic diseases

Identifiers

PMID37943614
PMCPMC10807710
OpenAlexW4388523802

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.